$PRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PAR PHARMACEUTICAL COMPANIES, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in PAR PHARMACEUTICAL COMPANIES, INC.. Get notifications about new insider transactions in PAR PHARMACEUTICAL COMPANIES, INC. for free.

Page: 1 2 3 4 5 ... 6 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	D	26.38	5,000	131,900	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	D	33.62	5,000	168,100	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	D	42.14	5,000	210,700	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	D	41.60	5,000	208,000	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	D	0.00	32,590	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	D	0.00	29,845	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Sell	D	50.00	70,000	3,500,000	9	70 K to 9 (-99.99 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	26.38	5,000	131,900	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	33.62	5,000	168,100	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	42.14	5,000	210,700	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	48.75	10,000	487,500	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	31.70	10,000	317,000	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	0.00	30,090	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	D	0.00	22,782	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	D	50.00	3,500	175,000	0	3.5 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	26.38	5,000	131,900	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	33.62	5,000	168,100	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	42.14	5,000	210,700	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	48.75	10,000	487,500	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	31.70	10,000	317,000	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	0.00	30,090	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	D	0.00	1,980	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	D	50.00	4,000	200,000	0	4 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	RICE THOMAS P	Director	Option Exercise	D	0.00	17,339	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	ZENNER PATRICK J	Director	Option Exercise	D	0.00	10,398	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	D	24.72	5,000	123,600	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	D	0.00	25,090	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	D	0.00	15,201	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	27.71	54,132	1,499,998	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	13.06	65,467	854,999	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	20.00	120,000	2,400,000	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	24.27	11,200	271,824	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	19.26	120,000	2,311,200	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	22.20	5,000	111,000	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	0.00	2,500	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Option Exercise	D	0.00	50,629	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Sell	D	50.00	15,000	750,000	0	15 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Sell	D	50.00	8,000	400,000	0	8 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Sell	D	50.00	15,000	750,000	8,000	23 K to 8 K (-65.22 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Sell	D	50.00	65,000	3,250,000	0	65 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Executive Chairman	Sell	D	50.00	126,792	6,339,600	65,000	191.8 K to 65 K (-66.11 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	32.76	22,894	750,007	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	36.54	16,420	599,987	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	27.71	6,025	166,953	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	27.71	2,095	58,052	6,025
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	13.06	20,100	262,506	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	24.27	4,700	114,069	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	33.62	875	29,418	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Option Exercise	D	24.29	30,000	728,700	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and Chief Finan ...	Sell	D	50.00	57,250	2,862,500	0	57.3 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	32.76	50,875	1,666,665	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	36.54	17,789	650,010	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	27.71	25,262	700,010	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	13.06	8,673	113,269	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	13.06	44,926	586,734	8,673
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	10.99	34,290	376,847	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	24.27	13,200	320,364	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	33.62	7,496	252,016	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	42.14	14,951	630,035	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	0.00	25,438	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	D	0.00	25,438	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Sell	D	50.00	900	45,000	0	900 to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Sell	D	50.00	69,648	3,482,400	0	69.6 K to 0 (-100.00 %)
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	32.76	50,875	1,666,665	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	36.54	17,789	650,010	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	27.71	17,593	487,502	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	13.06	27,000	352,620	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	13.06	22,771	297,389	27,000
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	10.99	34,290	376,847	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	24.27	3,175	77,057	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	33.62	4,497	151,189	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	42.14	8,970	377,996	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	0.00	25,438	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Option Exercise	D	0.00	25,438	0	0
Oct 02 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Executive Off ...	Sell	D	50.00	46,017	2,300,850	0	46 K to 0 (-100.00 %)
Jul 24 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	Executive Vice Pres ...	Payment of Exercise	F	50.19	624	31,319	57,250	57.9 K to 57.3 K (-1.08 %)
Jul 05 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	A	0.00	651	0	1,980
Jul 05 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	A	0.00	583	0	22,782
Jul 05 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	A	0.00	857	0	29,845
Jul 05 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	A	0.00	617	0	15,201
May 17 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and CFO	Payment of Exercise	F	40.34	903	36,427	57,874	58.8 K to 57.9 K (-1.54 %)
Apr 04 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	A	0.00	597	0	1,329
Apr 04 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	A	0.00	534	0	22,199
Apr 04 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	A	0.00	566	0	14,584
Apr 04 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	A	0.00	786	0	28,988
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	M	28.79	7,500	215,925	0
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.09	100	3,709	4,000	4.1 K to 4 K (-2.44 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.08	136	5,043	4,100	4.2 K to 4.1 K (-3.21 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.07	300	11,121	4,236	4.5 K to 4.2 K (-6.61 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.06	304	11,266	4,536	4.8 K to 4.5 K (-6.28 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.05	1,203	44,571	4,840	6 K to 4.8 K (-19.91 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.04	1,803	66,783	6,043	7.8 K to 6 K (-22.98 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.03	207	7,665	7,846	8.1 K to 7.8 K (-2.57 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.02	507	18,769	8,053	8.6 K to 8.1 K (-5.92 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	37.01	2,940	108,815	8,560	11.5 K to 8.6 K (-25.57 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Buy	M	28.79	7,500	215,925	11,500	4 K to 11.5 K (+187.50 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	M	28.79	7,500	215,925	0
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.05	1,300	48,166	3,500	4.8 K to 3.5 K (-27.08 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.05	700	25,935	4,800	5.5 K to 4.8 K (-12.73 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.03	100	3,703	5,500	5.6 K to 5.5 K (-1.79 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.03	500	18,515	5,600	6.1 K to 5.6 K (-8.20 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.02	600	22,212	6,100	6.7 K to 6.1 K (-8.96 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.01	800	29,609	6,700	7.5 K to 6.7 K (-10.67 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	37.01	3,500	129,535	7,500	11 K to 7.5 K (-31.82 %)
Mar 21 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Buy	M	28.79	7,500	215,925	11,000	3.5 K to 11 K (+214.29 %)
Jan 13 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and CFO	Payment of Exercise	F	35.65	482	17,183	58,777	59.3 K to 58.8 K (-0.81 %)
Jan 13 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Payment of Exercise	F	35.65	1,017	36,256	69,648	70.7 K to 69.6 K (-1.44 %)
Jan 13 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Chairman and CEO	Payment of Exercise	F	35.65	1,652	58,894	191,793	193.4 K to 191.8 K (-0.85 %)
Jan 13 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Payment of Exercise	F	35.65	1,102	39,286	46,106	47.2 K to 46.1 K (-2.33 %)
Jan 11 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Chairman and CEO	Payment of Exercise	F	35.09	5,365	188,258	193,445	198.8 K to 193.4 K (-2.70 %)
Jan 11 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and CFO	Payment of Exercise	F	35.09	481	16,878	59,259	59.7 K to 59.3 K (-0.81 %)
Jan 10 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	A	0.00	3,816	0	25,090
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Option Exercise	A	0.00	25,438	0	25,438
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Option Exercise	A	32.76	50,875	1,666,665	50,875
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Option Exercise	A	0.00	25,438	0	25,438
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Payment of Exercise	F	34.01	806	27,412	47,118	47.9 K to 47.1 K (-1.68 %)
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	A	0.00	25,438	0	25,438
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	A	32.76	50,875	1,666,665	50,875
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Option Exercise	A	0.00	25,438	0	25,438
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Payment of Exercise	F	34.01	744	25,303	70,665	71.4 K to 70.7 K (-1.04 %)
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP & CFO	Option Exercise	A	32.76	22,894	750,007	22,894
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP & CFO	Payment of Exercise	F	34.01	687	23,365	59,740	60.4 K to 59.7 K (-1.14 %)
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP & CFO	Grant	A	0.00	11,447	0	60,427	49 K to 60.4 K (+23.37 %)
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	A	0.00	3,816	0	30,090
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	A	0.00	3,816	0	30,090
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	RICE THOMAS P	Director	Option Exercise	A	0.00	3,816	0	17,339
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	A	0.00	3,816	0	32,590
Jan 09 2012	PRX	PAR PHARMACEUTICAL ...	ZENNER PATRICK J	Director	Option Exercise	A	0.00	3,816	0	10,398
Jan 06 2012	PRX	PAR PHARMACEUTICAL ...	LEPORE PATRICK G	Chairman and CEO	Payment of Exercise	F	32.17	2,941	94,612	198,810	201.8 K to 198.8 K (-1.46 %)
Jan 06 2012	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Payment of Exercise	F	32.17	1,062	34,165	47,924	49 K to 47.9 K (-2.17 %)
Jan 06 2012	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Payment of Exercise	F	32.17	1,057	34,004	71,409	72.5 K to 71.4 K (-1.46 %)
Jan 04 2012	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	A	0.00	655	0	21,665
Jan 06 2012	PRX	PAR PHARMACEUTICAL ...	Tropiano Michael A	EVP and CFO	Payment of Exercise	F	32.17	340	10,938	49,980	50.3 K to 50 K (-0.68 %)
Jan 04 2012	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	A	0.00	732	0	732
Jan 04 2012	PRX	PAR PHARMACEUTICAL ...	SMITH JOSEPH E	Director	Option Exercise	A	0.00	964	0	28,202
Jan 04 2012	PRX	PAR PHARMACEUTICAL ...	SHAROKY MELVIN MD	Director	Option Exercise	A	0.00	694	0	14,018
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Option Exercise	M	29.90	2,500	74,750	0
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	32.52	700	22,765	3,500	4.2 K to 3.5 K (-16.67 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	32.52	100	3,252	4,200	4.3 K to 4.2 K (-2.33 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	32.51	100	3,251	4,300	4.4 K to 4.3 K (-2.27 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	32.51	500	16,256	4,400	4.9 K to 4.4 K (-10.20 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Sell	S	32.51	1,100	35,761	4,900	6 K to 4.9 K (-18.33 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	KNIGHT PETER S	Director	Buy	M	29.90	2,500	74,750	6,000	3.5 K to 6 K (+71.43 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Option Exercise	M	29.90	2,500	74,750	0
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	32.50	100	3,250	4,000	4.1 K to 4 K (-2.44 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	32.50	2,200	71,500	4,100	6.3 K to 4.1 K (-34.92 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Sell	S	32.50	200	6,500	6,300	6.5 K to 6.3 K (-3.08 %)
Dec 19 2011	PRX	PAR PHARMACEUTICAL ...	NORDMANN RONALD M	Director	Buy	M	29.90	2,500	74,750	6,500	4 K to 6.5 K (+62.50 %)
Nov 22 2011	PRX	PAR PHARMACEUTICAL ...	HAUGHEY THOMAS	President	Payment of Exercise	F	29.56	6,589	194,771	72,466	79.1 K to 72.5 K (-8.33 %)
Nov 22 2011	PRX	PAR PHARMACEUTICAL ...	Campanelli Paul	Chief Operating Off ...	Payment of Exercise	F	29.56	7,009	207,186	49,794	56.8 K to 49.8 K (-12.34 %)

Page: 1 2 3 4 5 ... 6 next >